Survival of propofol infusion syndrome in a head-injured patient
| Autor: | Jill A. Rebuck, Christopher M. Greene, Stephanie Mallow Corbett, Frederick B. Rogers, Jesse Moore |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Adult
Male medicine.medical_specialty Resuscitation Traumatic brain injury Critical Care and Intensive Care Medicine Head trauma Norepinephrine Pharmacotherapy Intensive care Medicine Humans Vasoconstrictor Agents Infusions Intravenous Propofol Intracranial pressure business.industry medicine.disease Surgery Intensive Care Units Propofol infusion syndrome Anesthesia Brain Injuries Acidosis Lactic Drug Therapy Combination Intracranial Hypertension business Anesthetics Intravenous medicine.drug |
| Zdroj: | Critical care medicine. 34(9) |
| ISSN: | 0090-3493 |
| Popis: | To describe the clinical progression of an adult patient with traumatic brain injury who survived propofol infusion syndrome.Case report.Tertiary care surgical intensive care unit.A 21-yr-old male with traumatic brain injury was administered high doses of propofol for sedation and intracranial pressure control combined with vasopressor therapy to maintain cerebral perfusion pressure60 mmHg. He developed a significant metabolic acidosis with a lactic acid level of 10.9 mmol/L.Exploratory laparotomy, discontinuation of propofol infusion.An exploratory abdominal laparotomy was negative for traumatic injury. During the procedure, the propofol infusion was considered a possible cause and was discontinued. On review, it became apparent that a combination of high-dose propofol and catecholamines were responsible for the lactic acidosis. An echocardiogram revealed severe left ventricular dysfunction and cardiomyopathy, which resolved within 19 days.High-dose propofol should be avoided and alternative agents should be instituted for sedation and intracranial pressure management. The use of catecholamine infusions to maintain cerebral perfusion pressure in the setting of a high-dose propofol infusion may be pharmacologically unsound and may be a triggering factor for propofol infusion syndrome. Identification of the syndrome and discontinuation of propofol resulted in complete reversal of symptoms in the case described. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|